Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical News Today (MNT)
As GLP‑1 medications become widely used for obesity and metabolic disease, clinicians are confronting a growing question: What should be done when patients don’t respond as expected?
Endocrinology & Diabetes Nursing April 22nd 2026
SingleCare
Magnesium supplementation has been studied for blood pressure control, yet evidence remains mixed and effects appear modest and context‑dependent.
Ambulatory Care Nursing April 16th 2026
Health
Many adults remain unaware that processed meat is linked to colorectal cancer, highlighting the need for clearer communication around diet, risk magnitude, and screening.
Archives of Psychiatric Nursing
“The lived experience of youth who identify as TGD cannot be ignored and the belief that all youth have the inherent right to mental health care — regardless of gender or gender-identity — is reaffirmed.”
Family Nursing March 19th 2026
Cardiology Advisor
The Wegovy tablet is the first oral GLP-1 receptor agonist indicated for weight loss and cardiovascular risk reduction in eligible adults.
Endocrinology & Diabetes Nursing March 13th 2026
Healthline
“People are more used to taking pills than they are taking injections” but “90% of a person’s weight is the result of what they eat. There are no magic solutions.”
Ambulatory Care Nursing January 29th 2026